Pharmaceutical Antitrust

Global |  Publication |  May 2018

Download Pharmaceutical Antitrust 2018

We have contributed to Getting the Deal Through: Pharmaceutical Antitrust.

Getting the Deal Through is an international publication that provides international expert analysis in key areas of law, practice and regulation for corporate counsel, cross-border legal practitioners, and company directors and officers. Different chapters are written by experts in each area, and Norton Rose Fulbright is proud to present our latest contributions in Pharmaceutical Antitrust 2018.



Contacts

Stephen Nattrass
Stephen Nattrass
Partner
Email
stephen.nattrass@nortonrosefulbright.com
T: +1 613 780 1544
Erin Brown
Erin Brown
Partner
Email
erin.brown@nortonrosefulbright.com
T: +1 613 780 8618

Practice areas:

Industry:

Recent publications

City scape from overhead

Publication

Canadian employment and labour quarterly

This newsletter will keep employers up to date on Canadian employment and labour developments and best practices.

Canada | May 01, 2025

Employment and labour
Generic-building-skyscraper-windows-office

Publication

Faster USPTO patent grants after payment of issue fee

Effective May 13, 2025, the USPTO’s expected timeframe between issue notification and issue date will be approximately two weeks (instead of approximately three weeks)

Canada | April 28, 2025

Intellectual property
AI inspired face with light burst on head

Publication

Prosecuting AI-related patents in China

AI technology is flourishing in China, leading to a surge in innovators seeking to protect their intellectual property.

Canada | April 24, 2025

Artificial intelligence (AI)
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now